These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma. Abou-Taleb H; Yamaguchi K; Matsumura N; Murakami R; Nakai H; Higasa K; Amano Y; Abiko K; Yoshioka Y; Hamanishi J; Koshiyama M; Baba T; Yamada R; Matsuda F; Konishi I; Mandai M Oncotarget; 2016 Aug; 7(34):54758-54770. PubMed ID: 27340867 [TBL] [Abstract][Full Text] [Related]
7. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden. Naito T; Udagawa H; Umemura S; Sakai T; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuboi M; Ishii G; Goto K Lung Cancer; 2019 Dec; 138():35-42. PubMed ID: 31630044 [TBL] [Abstract][Full Text] [Related]
8. BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor? Jancewicz I; Siedlecki JA; Sarnowski TJ; Sarnowska E Epigenetics Chromatin; 2019 Nov; 12(1):68. PubMed ID: 31722744 [TBL] [Abstract][Full Text] [Related]
9. Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation. Marquez SB; Thompson KW; Lu L; Reisman D Front Oncol; 2014; 4():372. PubMed ID: 25774356 [TBL] [Abstract][Full Text] [Related]
10. BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions Marquez-Vilendrer SB; Rai SK; Gramling SJ; Lu L; Reisman DN Oncoscience; 2016; 3(11-12):337-350. PubMed ID: 28105458 [TBL] [Abstract][Full Text] [Related]
11. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2. Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623 [TBL] [Abstract][Full Text] [Related]
12. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines. Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481 [TBL] [Abstract][Full Text] [Related]
13. The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers. Savas S; Skardasi G Crit Rev Oncol Hematol; 2018 Mar; 123():114-131. PubMed ID: 29482773 [TBL] [Abstract][Full Text] [Related]
14. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes. Alpsoy A; Dykhuizen EC J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058 [TBL] [Abstract][Full Text] [Related]
15. Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway. Zhou Y; Xu Q; Tao L; Chen Y; Shu Y; Wu Z; Lu C; Shi Y; Bu H Clin Sci (Lond); 2020 Jun; 134(12):1457-1472. PubMed ID: 32514535 [TBL] [Abstract][Full Text] [Related]
17. SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability. Watanabe R; Ui A; Kanno S; Ogiwara H; Nagase T; Kohno T; Yasui A Cancer Res; 2014 May; 74(9):2465-75. PubMed ID: 24788099 [TBL] [Abstract][Full Text] [Related]
18. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma. Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303 [TBL] [Abstract][Full Text] [Related]